High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$24.5M
$24,455,066
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $87,902 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $41,281 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $86,303 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $112,084 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $315,096 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $143,416 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $118,430 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-04 | $43,069 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $53,222 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $132,440 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $114,474 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $238,051 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $139,373 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $458,410 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $545,446 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $357,542 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $124,016 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-03-02 | $64,724 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
Sell to Cover
2026-02-13
$2,157,542Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-02-13 | $2,157,542Large | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $44,327 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $35,515 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $115,786 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $87,426 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $95,538 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $93,652 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $216,802 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $278,664 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $192,858 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $353,016 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $225,545 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $168,144 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $109,429 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $459,321 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $509,956 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $95,891 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $215,274 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $93,478 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $43,763 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $7,822 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2026-01-12 | $32,951 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $99,988 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $199,920 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $99,898 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Equity Compensation
|
2025-11-26 | $0 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-26 | $99,950 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $399,965 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $119,024 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $88,665 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-13 | $1,191,300Large | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $292,815 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $454,594 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $664,680 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $999,630 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $769,202 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-13 | $724,107 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $197,121 | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
10b5-1 Sell
2025-11-12
$1,105,069Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $1,105,069Large | S | Form 4 |
|
ALNY
S
ALNYLAM PHARMACEUTICALS, INC.
Greenstreet Yvonne
• CEO
10b5-1 Sell
2025-11-12
$1,551,637Large
|
||||||
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $1,551,637Large | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $891,486 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $484,813 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $547,440 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $566,206 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $203,927 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $957,588 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $318,578 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-12 | $1,786,950Large | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-11-12 | $27,443 | M | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-11-12 | $276,457 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $453,316 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $337,036 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $100,736 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $204,014 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $4,119 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $245,926 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $76,594 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $156,286 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $918,508 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $456,379 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $740,230 | S | Form 4 |
| ALNY |
ALNYLAM PHARMACEUTICALS, INC.
|
CEO
Sell to Cover
|
2025-10-02 | $340,941 | S | Form 4 |